Ismo
Treatment
2 FDA approvals
0 Active Studies for Ismo
What is Ismo
Vismodegib
The Generic name of this drug
Treatment Summary
Vismodegib is a medication used to treat adult basal cell carcinoma, a form of skin cancer. It works by blocking the hedgehog signaling pathway. This drug was approved by the FDA in 2012.
Erivedge
is the brand name
Ismo Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Erivedge
Vismodegib
2012
1
Approved as Treatment by the FDA
Vismodegib, also called Erivedge, is approved by the FDA for 2 uses such as metastatic Basal cell carcinoma and Locally Advanced Basal Cell Carcinoma .
metastatic Basal cell carcinoma
Locally Advanced Basal Cell Carcinoma
Effectiveness
How Ismo Affects Patients
Vismodegib blocks a specific protein (SMO) that is involved in the Hedgehog signalling pathway. This stops the pathway from working properly.
How Ismo works in the body
Vismodegib works by targeting a protein called Smoothened homologue (SMO). This protein is involved in a process called the Hedgehog pathway, which helps control the growth and division of skin cells. By blocking SMO, Vismodegib prevents the Hedgehog pathway from working properly, which can help reduce the uncontrolled growth of skin cells.
Warnings
Ismo Contraindications
Condition
Risk Level
Notes
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with Ismo.
Common Ismo Drug Interactions
Drug Name
Risk Level
Description
Ozanimod
Major
Vismodegib may decrease the excretion rate of Ozanimod which could result in a higher serum level.
Rimegepant
Major
The serum concentration of Rimegepant can be increased when it is combined with Vismodegib.
(S)-Warfarin
Minor
The metabolism of (S)-Warfarin can be decreased when combined with Vismodegib.
Abrocitinib
Minor
The metabolism of Abrocitinib can be decreased when combined with Vismodegib.
Asunaprevir
Minor
The metabolism of Asunaprevir can be decreased when combined with Vismodegib.
Ismo Toxicity & Overdose Risk
Taking this drug increases the risk of fetal death and severe birth defects. Common side effects include muscle spasms, hair loss, changes in taste, weight loss, tiredness, nausea, diarrhea, decreased appetite, constipation, joint pain, vomiting, and loss of taste.
Ismo Reviews: What are patients saying about Ismo?
5
Patient Review
1/4/2009
Ismo for Angina Pectoris Prevention
2.3
Patient Review
3/27/2011
Ismo for Angina Pectoris Prevention
2
Patient Review
4/16/2021
Ismo for prevention of anginal chest pain associated with coronary artery disease
Patient Q&A Section about ismo
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Where IS ISMO from?
"Jyväskylä is situated in the western part of the Finnish Lakeland, approximately 150 km north-east of Tampere and 270 km north of Helsinki."
Answered by AI